Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2014 | 0.9913 |
| April 30, 2014 | 0.4818 |
| January 31, 2014 | 0.4718 |
| October 31, 2013 | 0.5666 |
| Date | Value |
|---|---|
| July 31, 2013 | 0.8112 |
| April 30, 2013 | 0.8691 |
| January 31, 2013 | |
| October 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Oramed Pharmaceuticals Inc | -- |
| Viking Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.26M |
| Total Liabilities (Quarterly) | 14.45M |
| Shareholders Equity (Quarterly) | 72.81M |